Avesta Ketamine & Wellness

What Avesta Ketamine & Wellness does

Avesta Ketamine & Wellness is a privately held, multi-location ketamine therapy practice headquartered in Bethesda, Maryland, serving patients across the Washington DC, Maryland, and Virginia (DMV) metropolitan area through five clinics (Bethesda, Columbia, Tysons, Norfolk, and Washington DC). The company administers IV racemic ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, Ketamine-Assisted Psychotherapy, and integration coaching for treatment-resistant depression, anxiety disorders, PTSD, chronic pain conditions such as CRPS and fibromyalgia, and other mental health conditions. Its clinical differentiation rests on a protocol that combines pharmacological ketamine with coordinated care, patient education, and a curated network of external therapists and psychiatrists for post-treatment integration.

The company generates revenue primarily through fee-for-service clinical treatments, with Spravato more likely to be covered by insurance while IV ketamine is often paid out-of-pocket or via HSA/FSA accounts. Pricing is not publicly disclosed. GTM motion is sales-led and consultation-driven: free initial consultations determine candidacy, supported by a referral network of psychiatrists, pain management doctors, and primary care physicians. Marketing is anchored by educational content, webinars, Google reviews, and earned media including coverage in the Baltimore Business Journal for the 2025 Columbia, MD clinic opening. The practice is founder-led, co-led by Dr. Ladan Eshkevari (Georgetown University Professor Emeritus with 25+ years in nurse anesthesia) and Deborah Tan, with no disclosed external institutional investment.

Name

Avesta Ketamine & Wellness

Legal name

Avesta Ketamine and Wellness

Website

https://avestaketaminewellness.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Avesta Ketamine & Wellness is a private, founder-led ketamine therapy practice operating five clinics across the DC, Maryland, and Virginia region, treating treatment-resistant depression, anxiety, PTSD, and chronic pain with IV ketamine, Spravato, and integrative psychotherapy.

Ownership category

akta.pro rank

Product category

Ketamine Therapy Clinics

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Spas (Medi-Spa) (HSADAKAB)

akta.pro secondary industries

Holistic & Alternative Therapies (Reiki, Sound Healing, Breathwork, Energy Work) (THAJAHAF), Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)

Keywords

• Ketamine therapy
• Depression treatment
• Spravato esketamine
• Chronic pain management
• Ketamine assisted psychotherapy

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Treatment Services: Fee-for-service clinical treatments including IV ketamine infusions, Spravato nasal spray treatments, and related therapeutic services. Revenue generated through per-treatment billing with typical treatment protocols of 6-8 sessions for mood disorders.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Avesta Ketamine & Wellness is a multi-location clinical practice that administers intravenous ketamine infusions and FDA-approved Spravato (esketamine) nasal spray for patients with treatment-resistant depression, anxiety disorders, PTSD, and chronic pain. It complements these core treatments with ketamine-assisted psychotherapy (KAP), integration coaching, IV vitamin infusions, and telemedicine-based medical cannabis certification for Virginia residents.

Product overview

Avesta Ketamine & Wellness operates as a multi-location ketamine therapy practice offering a portfolio of six distinct treatment services. The core offerings are IV Ketamine Therapy (racemic intravenous infusions) and Spravato™ (FDA-approved esketamine nasal spray) for treating treatment-resistant depression, anxiety, PTSD, and chronic pain. These are complemented by Ketamine-Assisted Psychotherapy (KAP) and Ketamine Integration Coaching, which combine ketamine administration with therapeutic support to help patients process and integrate their treatment experiences. Additional wellness services include IV Vitamin Infusions and Medical Cannabis Certification (Virginia only). The practice serves patients across the DMV area through five clinic locations.

Differentiator

Problem solved

Functional benefit

Products and services

• IV Ketamine Therapy Intravenous infusions of racemic ketamine administered at subanesthetic doses (typically over 40 minutes) targeting NMDA receptors in the glutamatergic system. Indicated for patients with treatment-resistant depression, anxiety disorders, PTSD, and chronic pain conditions unresponsive to standard treatments.
• Spravato (esketamine) FDA-approved nasal spray containing esketamine (S-ketamine) administered under medical supervision for treatment-resistant major depressive disorder, including patients with suicidal ideation. Used in conjunction with an oral antidepressant and billed under REMS program requirements.
• Ketamine-Assisted Psychotherapy (KAP) Combines ketamine administration with concurrent psychotherapy sessions to enable deeper emotional processing and therapeutic breakthroughs during the ketamine experience. Integrates mental health professional support during infusion sessions.
• Ketamine Integration Coaching Guidance and support services that help patients process and integrate insights gained during ketamine experiences, including psychedelic coaching to optimize therapeutic outcomes beyond the immediate treatment window.
• IV Vitamin Infusions Nutrient-rich intravenous infusions designed for general wellness support and complementary health optimization, offered alongside ketamine therapy protocols.
• Medical Cannabis Certification Certification services that allow Virginia residents to access medical cannabis through telemedicine appointments, offered as a complementary treatment option for qualifying patients.

Quantifiable outcome

• 75-80% success rate in mood disorder patients aged 14-65
• +2 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered minor and core.

• ASKP (American Society of Ketamine Physicians)minorOthersProfessional organization membership displaying ASKP logo on website footer. ASKP is a professional medical society for ketamine providers.
• Virginia Mental Health Legislative Committee (VMHLC)minorOthersOrganization affiliation displayed on website footer. VMHLC appears to be a Virginia mental health advocacy organization.
• Ten Ten LifeminorOthersPartnership organization whose logo appears on Avesta website footer.
• Recommended Therapist and Psychiatrist NetworkcoreStrategic or Co-development PartnerAvesta maintains a curated network of recommended therapists and psychiatrists to support integrative ketamine therapy. These mental health professionals provide therapy and coaching services that complement ketamine treatments, helping patients integrate their experiences and achieve optimal outcomes. The company provides a referral list of vetted providers on their website.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mindbloom: National ketamine therapy provider offering both at-home and in-clinic protocols. Most directly comparable peer in terms of core service (ketamine for mood disorders) and patient demographic, with materially larger scale and capital.
• Nue Life: National ketamine therapy platform combining infusion treatments with digital integration support. Comparable to Avesta in offering ketamine for depression/anxiety/PTSD with a hybrid in-clinic and coaching model.
• Journey Clinical: Ketamine therapy provider operating through a network of clinicians offering in-person and telehealth ketamine treatment. Comparable service model targeting the same treatment-resistant mental health population.
• Klarity: Provider of ketamine and psychedelic-assisted therapy services for treatment-resistant mental health conditions. Directly comparable in scope, including combination of ketamine administration with integration therapy.
• Ketamine Wellness Centers: Multi-state ketamine clinic chain offering IV ketamine infusions for depression, PTSD, and chronic pain. Direct competitor with a clinic-based, multi-location operating model analogous to Avesta's.

Emerging players

• Cerebral: Online mental health platform offering telehealth psychiatry and medication management. Partial overlap with Avesta's behavioral health treatment scope, though Cerebral operates a broader, medication-forward model rather than ketamine specialization.
• Talkiatry: Online psychiatry practice providing in-network mental health treatment via telehealth. Comparable in targeting treatment-resistant depression and anxiety populations, though Talkiatry is medication-centric rather than ketamine-focused.
• Brightside Health: Telehealth mental health platform specializing in depression and anxiety treatment with medication and therapy services. Partial overlap in addressing treatment-resistant mood disorders, but no ketamine offering.

Broad incumbents

• Restore Hyper Wellness: National franchise offering IV vitamin infusions, cryotherapy, and wellness services. Comparable in providing clinical-grade IV infusion services in multi-location settings, though Restore operates in the wellness/preventive category rather than mental health treatment.
• U.S. Anesthesia Partners: Large national anesthesia physician group. Comparable to Avesta's founder expertise (Georgetown nurse anesthesia background) and clinical staffing model, though USAP operates at far greater scale across surgical settings rather than ketamine clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Facebookfacebook.com/avestaketaminewellness
• LinkedInlinkedin.com/company/avesta-ketamine-and-wellness

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avesta Ketamine & Wellness